Abbott Park, Illinois (ots-PRNewswire) - Abbott Laboratories today
announced that Thomas C. Freyman has been elected senior vice
president, finance and chief financial officer by the board of
directors of Abbott Laboratories effective April 1, 2001. Freyman has
been vice president, hospital products controller at Abbott.
Freyman, 46, succeeds Gary P. Coughlan, who will retire on March
31, 2001. Coughlan has served as senior vice president, finance and
chief financial officer since joining the company in May 1990.
"Tom is a highly regarded 22-year Abbott veteran with broad
experience in international finance, treasury and the controller
function," Miles D. White, chairman and chief executive officer,
said. "We are extremely pleased to have strong internal talent to
ensure a smooth transition for this critical position."
Freyman holds a bachelor's degree in accounting from the
University of Illinois and a master's degree in management from
Northwestern University's Kellogg Graduate School of Management.
Freyman is a member of the American Institute of Certified Public
Accountants and of the board of directors of Victory/St. Therese
Enterprises, Inc., United Way of Lake County, and the University of
Illinois Business Advisory Council.
In commenting on Coughlan's retirement, White said, "Gary has made
significant contributions to the growth and success of Abbott. He has
been instrumental in supporting Abbott's long tradition of financial
stability and our more aggressive approach to external
collaborations. He has led our e-commerce initiatives and developed a
depth of leadership talent in finance and the other organisations he
oversees. We thank him for his strong leadership and wish him the
best in his retirement."
Abbott Laboratories is a global, diversified health care company
devoted to the discovery, development, manufacture and marketing of
pharmaceutical, diagnostic, nutritional and hospital products. The
company employs 60,000 people and markets its products in more than
130 countries. In 2000, the company's sales and net earnings were
$13.7 billion and $2.8 billion, respectively, with diluted earnings
per share of $1.78.
Abbott's news releases and other information are available on the
company's Web site at http://www.abbott.com
ots Original Text Service: Abbott Laboratories
Media, Kathleen O'Neil, +1-847-938-3895, or
Financial Community, John Thomas, +1-847-938-2655,
both of Abbott Laboratories.
Company News On-Call:
fax, +1-800-758-5804, ext. 110328
Web site: http://www.abbott.com
Original-Content von: Abbott Laboratories, übermittelt durch news aktuell